1 | 5-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride | 1件: 2,4-thiazolidinedione 2,4-thiazolidinedione | - | - | - | 1件: 20 20 |
2 | 5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride | 1件: 2,4-thiazolidinedione 2,4-thiazolidinedione | - | - | - | 1件: 20 20 |
3 | 5-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE HYDROCHLORIDE | 1件: 2,4-thiazolidinedione 2,4-thiazolidinedione | - | - | - | 1件: 20 20 |
4 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 20件: 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
5 | Albumin | - | - | - | - | 3件: 2 2, 20, 51 |
6 | Albumin solution | - | - | - | - | 1件: 20 20 |
7 | Albunorm® 5%, | - | - | - | - | 1件: 20 20 |
8 | ALEMTUZUMAB | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 17件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
9 | Allogeneic stem cell transplantation | - | - | - | - | 5件: 19 19, 20, 49, 62, 84 |
10 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA | - | - | - | - | 1件: 20 20 |
11 | Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA | - | - | - | - | 1件: 20 20 |
12 | Bezafibrate | 1件: Bezafibrate Bezafibrate | 1件: D01366
D01366
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 20 20, 93, 94, 160, 296, 316, 324 |
13 | BIOTIN | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 5件: 2 2, 8, 10, 13, 20 |
14 | Busulfan | 1件: Busulfan Busulfan | 1件: D00248
D00248
| - | - | 13件: 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
15 | Busulfan, Cyclophosphamide, Antithymocyte Globulin | 2件: Busulfan Busulfan, Cyclophosphamide | 3件: D00248
D00248
,
D00287
,
D07760
| - | - | 2件: 19 19, 20 |
16 | CALD HR-D (High-Risk, Regimen C) | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
17 | CALD HR-D (High-Risk, Regimen D) | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
18 | CALD SR-A (Standard-Risk, Regimen A) | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
19 | CALD SR-B (Standard-Risk, Regimen B) | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
20 | Campath | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 12件: 19 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 |
21 | Campath-1H | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 6件: 19 19, 20, 60, 234, 285, 326 |
22 | Chenodeoxycholic acid | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: D00163
D00163
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 4件: 20 20, 96, 234, 263 |
23 | Cholic Acid | 1件: Cholic Acid Cholic Acid | 1件: D10699
D10699
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 4件: 20 20, 234, 265, 310 |
24 | Cholic Acids | - | - | - | - | 2件: 20 20, 234 |
25 | Clofarabine | 1件: Clofarabine Clofarabine | 1件: D03546
D03546
| 3件: POLA1 POLA1, POLA2, RRM1 💬 | 6件: DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 9件: 19 19, 20, 40, 46, 49, 60, 96, 234, 326 |
26 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 45件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
27 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 37件: 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 |
28 | Cyclosporine A | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 234, 283 |
29 | D-BIOTIN | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 3件: 10 10, 13, 20 |
30 | DUOC-01 | - | - | - | - | 3件: 13 13, 19, 20 |
31 | Elivaldogene autotemcel | 1件: Elivaldogene autotemcel Elivaldogene autotemcel | 1件: D12150
D12150
| 1件: ABCD1 ABCD1 💬 | 2件: ABC transporters ABC transporters, Peroxisome 💬 | 1件: 20 20 |
32 | Elivaldogenum tavalentivecum | - | - | - | - | 1件: 20 20 |
33 | Glyceryl Trierucate | 1件: Glyceryl Trierucate Glyceryl Trierucate | - | - | - | 1件: 20 20 |
34 | Glyceryl trierucate/glyceryl trioleate | 2件: Glyceryl Trierucate Glyceryl Trierucate, Glyceryl Trioleate | - | - | - | 1件: 20 20 |
35 | Glyceryl Trioleate | 1件: Glyceryl Trioleate Glyceryl Trioleate | - | - | - | 1件: 20 20 |
36 | Hematopoietic stem cell infusion | - | - | - | - | 2件: 19 19, 20 |
37 | Hematopoietic Stem Cell Transplantation | - | - | - | - | 13件: 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 |
38 | Human Placental Derived Stem Cell | - | - | - | - | 4件: 19 19, 20, 60, 284 |
39 | Hydroxyurea | 1件: Hydroxyurea Hydroxyurea | 1件: D00341
D00341
| 1件: RRM2 RRM2 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
40 | IMD | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
41 | IMD Preparative Regimen | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
42 | Interferon Beta | 1件: Human interferon beta Human interferon beta | - | - | - | 6件: 13 13, 20, 26, 50, 96, 97 |
43 | Lenti-D Drug Product | - | - | - | - | 1件: 20 20 |
44 | Leriglitazone | 1件: Leriglitazone Leriglitazone | 1件: D11603
D11603
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 20 20 |
45 | Lipoic acid | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 5件: 2 2, 5, 13, 14, 20 |
46 | Lorenzo's Oil | - | - | - | - | 1件: 20 20 |
47 | MD1003 | - | - | - | - | 5件: 2 2, 10, 13, 14, 20 |
48 | MD1003 100 mg capsule | - | - | - | - | 1件: 20 20 |
49 | Melphalan | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
50 | Mesenchymal stem cells | - | - | - | - | 11件: 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
51 | MIN-102 | - | - | - | - | 2件: 18 18, 20 |
52 | Modified cobratoxin | - | - | - | - | 1件: 20 20 |
53 | Mycophenolate | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
54 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
55 | Mycophenylate mofetil | - | - | - | - | 2件: 19 19, 20 |
56 | N-Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 11件: 6 6, 13, 19, 20, 49, 58, 85, 111, 164, 299, 337 |
57 | NV1205 | - | - | - | - | 1件: 20 20 |
58 | Osteopetrosis Haploidentical Only Preparative Regimen | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
59 | Osteopetrosis Only Preparative Regimen | - | - | - | - | 5件: 19 19, 20, 125, 234, 326 |
60 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
61 | PLERIXAFOR | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 20 20, 51, 65, 285, 299 |
62 | Pramipexole | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 20 |
63 | PXL065 | - | - | - | - | 1件: 20 20 |
64 | PXL770 | - | - | - | - | 1件: 20 20 |
65 | QTXEW2-04-AF, EW2, GC-1, QRX-431 | - | - | - | - | 1件: 20 20 |
66 | RPI78M for injection | - | - | - | - | 1件: 20 20 |
67 | Sobetirome | 1件: Sobetirome Sobetirome | 1件: D09381
D09381
| 1件: THRB THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 1件: 20 20 |
68 | Sobetirome (NV1205) | 1件: Sobetirome Sobetirome | 1件: D09381
D09381
| 1件: THRB THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 1件: 20 20 |
69 | Stem Cell Transplant | - | - | - | - | 6件: 19 19, 20, 60, 65, 164, 284 |
70 | Stem Cell Transplantation | - | - | - | - | 13件: 13 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 |
71 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: D00754
D00754
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
72 | Thiazolidinedione | 1件: 2,4-thiazolidinedione 2,4-thiazolidinedione | - | - | - | 1件: 20 20 |
73 | Thiotepa | 1件: Thiotepa Thiotepa | 1件: D00583
D00583
| - | - | 12件: 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 |
74 | Thiotepa--escalated dose | 1件: Thiotepa Thiotepa | 1件: D00583
D00583
| - | - | 4件: 19 19, 20, 65, 284 |
75 | Thiotepa--single daily dose | 1件: Thiotepa Thiotepa | 1件: D00583
D00583
| - | - | 4件: 19 19, 20, 65, 284 |
76 | Total body Irradiation | - | - | - | - | 6件: 19 19, 20, 51, 60, 65, 285 |
77 | Ursodiol | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 6件: 8 8, 20, 93, 97, 234, 299 |
78 | Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 12件: 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 |
79 | Vitamin E | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 11件: 2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 |
80 | VK0214 | - | - | - | - | 1件: 20 20 |